MVCAX
Price
$34.06
Change
+$0.04 (+0.12%)
Updated
Jul 13 closing price
Net Assets
17.25B
TSMVX
Price
$31.24
Change
+$0.13 (+0.42%)
Updated
Jul 13 closing price
Net Assets
640.22M
Interact to see
Advertisement

MVCAX vs TSMVX

MVCAX vs TSMVX Comparison Chart in %
View a ticker or compare two or three
VS
MVCAX vs. TSMVX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVCAX is a Hold and TSMVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.2B vs. TSMVX (640M). TSMVX pays higher dividends than MVCAX: TSMVX (1.19) vs MVCAX (1.11). MVCAX was incepted earlier than TSMVX: MVCAX (25 years) vs TSMVX (21 years). MVCAX (0.98) is less costly to investors than TSMVX (0.81). TSMVX is a more actively managed with annual turnover of: 48.00 vs. MVCAX (24.00). TSMVX has a lower initial minimum investment than MVCAX: TSMVX (0) vs MVCAX (1000). TSMVX annual gain was more profitable for investors over the last year : 10.72 vs. MVCAX (9.45). MVCAX return over 5 years is better than : 17.60 vs. TSMVX (-1.46).
MVCAXTSMVXMVCAX / TSMVX
Total Expense Ratio0.970.81120%
Annual Report Gross Expense Ratio0.980.81121%
Fund Existence25 years21 years-
Gain YTD13.13613.127100%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets17.2B640M2,688%
Annual Yield % from dividends1.111.1993%
Returns for 1 year9.4510.7288%
Returns for 3 years20.0614.27141%
Returns for 5 years17.60-1.46-1,206%
Returns for 10 years82.5727.03305%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GQSCX19.16N/A
N/A
Glenmede Disciplined US Small Cap Eq Ptf
RGNCX55.35N/A
N/A
Victory Global Energy Transition C
BDHIX9.07N/A
N/A
BlackRock Dynamic High Income Instl
VESMX22.21N/A
N/A
VELA Small Cap I
JFNIX88.56-0.69
-0.77%
Janus Henderson Global Life Sciences I